UTSW First in Texas to Offer Novel Treatment for Rare Eye Cancer That Spreads to the Liver
UT Southwestern Medical Center became the first in Texas and the surrounding region to successfully perform a novel whole liver chemotherapy procedure using the FDA-approved Hepzato Kit to treat metastatic uveal melanoma, a rare and deadly form of eye cancer that commonly spreads to the liver. This breakthrough approach isolates liver circulation to deliver high-dose chemotherapy directly to tumors, aiming to improve disease control and survival for patients with few treatment options. 
UTSW First in Texas to Offer Novel Treatment for Rare Eye Cancer That Spreads to the Liver